These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 19084337

  • 21. Decreased neural stem/progenitor cell proliferation in mice with chronic/nonremitting experimental autoimmune encephalomyelitis.
    Guo J, Li H, Yu C, Liu F, Meng Y, Gong W, Yang H, Shen X, Ju G, Li Z, Wang J.
    Neurosignals; 2010; 18(1):1-8. PubMed ID: 19786810
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response.
    Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y.
    J Neuroimmunol; 2008 Feb; 194(1-2):107-14. PubMed ID: 18207251
    [Abstract] [Full Text] [Related]

  • 27. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf AF, Melief MJ, Hintzen RQ, 't Hart BA, Amor S, Boven LA, Laman JD.
    J Pathol; 2009 Mar; 217(4):543-51. PubMed ID: 19023878
    [Abstract] [Full Text] [Related]

  • 28. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 29. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis.
    Nicholas AP, Sambandam T, Echols JD, Barnum SR.
    J Comp Neurol; 2005 Jun 06; 486(3):254-66. PubMed ID: 15844173
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
    Spach KM, Pedersen LB, Nashold FE, Kayo T, Yandell BS, Prolla TA, Hayes CE.
    Physiol Genomics; 2004 Jul 08; 18(2):141-51. PubMed ID: 15138306
    [Abstract] [Full Text] [Related]

  • 32. Targeted expression of IGF-1 in the central nervous system fails to protect mice from experimental autoimmune encephalomyelitis.
    Genoud S, Maricic I, Kumar V, Gage FH.
    J Neuroimmunol; 2005 Nov 08; 168(1-2):40-5. PubMed ID: 16120466
    [Abstract] [Full Text] [Related]

  • 33. A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ, Parmar A, Miller B, Stephan J, Tenorio G, Tran K, Leighton J, Kerr BJ.
    Pain; 2010 Jun 08; 149(3):565-572. PubMed ID: 20399559
    [Abstract] [Full Text] [Related]

  • 34. Opioid growth factor arrests the progression of clinical disease and spinal cord pathology in established experimental autoimmune encephalomyelitis.
    Campbell AM, Zagon IS, McLaughlin PJ.
    Brain Res; 2012 Sep 07; 1472():138-48. PubMed ID: 22820301
    [Abstract] [Full Text] [Related]

  • 35. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
    Qu XX, Cai J, Li MJ, Chi YN, Liao FF, Liu FY, Wan Y, Han JS, Xing GG.
    Exp Neurol; 2009 Feb 07; 215(2):298-307. PubMed ID: 19046970
    [Abstract] [Full Text] [Related]

  • 36. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA, Wong G, Tenorio G, Baker GB, Kerr BJ.
    Behav Brain Res; 2013 Sep 01; 252():302-11. PubMed ID: 23777648
    [Abstract] [Full Text] [Related]

  • 37. Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
    Irony-Tur-Sinai M, Grigoriadis N, Lourbopoulos A, Pinto-Maaravi F, Abramsky O, Brenner T.
    Exp Neurol; 2006 Mar 01; 198(1):136-44. PubMed ID: 16423348
    [Abstract] [Full Text] [Related]

  • 38. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, Kilpatrick TJ, Butzkueven H.
    J Neurosci Res; 2008 Dec 01; 86(16):3548-55. PubMed ID: 18709652
    [Abstract] [Full Text] [Related]

  • 39. Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice.
    Gomez-Nicola D, Spagnolo A, Guaza C, Nieto-Sampedro M.
    Exp Neurol; 2010 Apr 01; 222(2):235-42. PubMed ID: 20070942
    [Abstract] [Full Text] [Related]

  • 40. Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.
    Lu J, Kurejova M, Wirotanseng LN, Linker RA, Kuner R, Tappe-Theodor A.
    J Neuroinflammation; 2012 Oct 06; 9():233. PubMed ID: 23039175
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.